The Only Complete Online Marketing Firm
Saturday, October 8, 2016
PARP Inhibitor Broadly Active in Ovarian Cancer
(MedPage Today) -- Significant PFS benefit regardless of BRCA status
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment